TheNote.app
Sign In
Sign Up
RSS European Medicines Agency (EMA) | Human medicine and SMOPs
Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 19, Status: Authorised
www.ema.europa.eu
www.ema.europa.eu
